GURUFOCUS.COM » STOCK LIST » Real Estate » REITs » BioMed Realty Trust Inc (NYSE:BMR) » Definitions » EPS (Diluted)

BioMed Realty Trust (BioMed Realty Trust) EPS (Diluted) : $0.93 (TTM As of Sep. 2015)


View and export this data going back to . Start your Free Trial

What is BioMed Realty Trust EPS (Diluted)?

BioMed Realty Trust's Earnings per Share (Diluted) for the three months ended in Sep. 2015 was $0.14. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2015 was $0.93.

BioMed Realty Trust's EPS (Basic) for the three months ended in Sep. 2015 was $0.14. Its EPS (Basic) for the trailing twelve months (TTM) ended in Sep. 2015 was $1.05.

BioMed Realty Trust's EPS without NRI for the three months ended in Sep. 2015 was $0.13. Its EPS without NRI for the trailing twelve months (TTM) ended in Sep. 2015 was $0.92.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.


BioMed Realty Trust EPS (Diluted) Historical Data

The historical data trend for BioMed Realty Trust's EPS (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioMed Realty Trust EPS (Diluted) Chart

BioMed Realty Trust Annual Data
Trend Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14
EPS (Diluted)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.19 0.19 -0.03 0.20 0.98

BioMed Realty Trust Quarterly Data
Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15
EPS (Diluted) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.08 0.60 0.08 0.11 0.14

Competitive Comparison of BioMed Realty Trust's EPS (Diluted)

For the REIT - Office subindustry, BioMed Realty Trust's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BioMed Realty Trust's PE Ratio Distribution in the REITs Industry

For the REITs industry and Real Estate sector, BioMed Realty Trust's PE Ratio distribution charts can be found below:

* The bar in red indicates where BioMed Realty Trust's PE Ratio falls into.



BioMed Realty Trust EPS (Diluted) Calculation

EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.

BioMed Realty Trust's Diluted EPS for the fiscal year that ended in Dec. 2014 is calculated as

Diluted EPS (A: Dec. 2014 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(193.778-0)/207.233
=0.94

BioMed Realty Trust's Diluted EPS for the quarter that ended in Sep. 2015 is calculated as

Diluted EPS (Q: Sep. 2015 )=(Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(28.203-0)/207.802
=0.14

EPS (Diluted) for the trailing twelve months (TTM) ended in Sep. 2015 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.93

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


BioMed Realty Trust  (NYSE:BMR) EPS (Diluted) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


BioMed Realty Trust EPS (Diluted) Related Terms

Thank you for viewing the detailed overview of BioMed Realty Trust's EPS (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.


BioMed Realty Trust (BioMed Realty Trust) Business Description

Traded in Other Exchanges
N/A
Address
BioMed Realty Trust Inc, a Maryland corporation was formed on April 30, 2004 and commenced operations on August 11, 2004, after completing its initial public offering. The Company operates as a self-administered and self-managed real estate investment trust focused on acquiring, developing, owning, leasing and managing laboratory and office space for the life science industry mainly through its subsidiary, BioMed Realty, L.P., a Maryland limited partnership Its tenants mainly include biotechnology and pharmaceutical companies, scientific research institutions, government agencies and other entities involved in the life science industry. The Company's properties are generally located in markets with well established reputations as centers for scientific research, including Boston, San Diego, San Francisco, Seattle, Maryland, Pennsylvania and New York/ New Jersey. The Company faces competition from various entities for investment opportunities in properties for life science tenants, including other REITs, such as health care REITs and suburban office property REITs, pension funds, insurance companies, investment funds and companies, partnerships, and developers. The Company's properties are subject to various laws, ordinances and regulations, including regulations relating to common areas.
Executives
Daniel Bradbury director BIOBRIT, LLC, 2223 AVENIDA DE LA PLAYA, SUITE 108, LA JOLLA CA 92037
Brody William R Md Phd director MEDTRONIC, INC, 710 MEDTRONIC PKWY, MS LC310, MINNEAPOLIS MN 55432-5604
Janice L. Sears director 1100 PARK PLACE, SUITE 200, SAN MATEO CA 94403
Alan D Gold director, officer: Chairman, President and CEO 17140 BERNARDO CENTER DRIVE, SUITE 195, SAN DIEGO CA 92128
Gary A Kreitzer director, officer: Exec VP and Assistant Sec 17140 BERNARDO CENTER DRIVE, SUITE 195, SAN DIEGO CA 92128
Margaret Faye Wilson director 12836 LUNADA PLACE, SAN DIEGO CA 92128
Griffin R Kent Jr officer: President and COO 5950 SHERRY LANE, SUITE 700, DALLAS TX 75225
Richard I Gilchrist director 5950 SHERRY LANE, SUITE 700, DALLAS TX 75225